Patient records
Name: Ahmed (pseudonym)
Age: 38
Nationality: Dubai, United Arab Emirates
Diagnosis: Dilated cardiomyopathy, end-stage heart failure, post-cardiac resynchronization therapy (CRT-D)
Treatment Hospital: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Heart transplantation is the last hope for patients with end-stage heart failure. But when this "heart of hope" needs to be found across borders, patients face not only the complex rules of organ allocation, but also the enormous challenge of completing this life-saving relay in a foreign land. Ahmed's story tells how we can become the most reliable coordinators in this "transnational life-saving relay."
1. A heart that is "shutting down"
Ahmed was diagnosed with dilated cardiomyopathy at age 35, with his heart enlarged to twice its normal size. An echocardiogram revealed a left ventricular ejection fraction (EF) of only 15% (normal >50%), indicating severe left ventricular systolic dysfunction, with his heart pumping only one-third the normal capacity. Despite receiving optimized drug therapy (GDMT) and cardiac resynchronization therapy (CRT-D) in Dubai and London, his condition continued to deteriorate. He was repeatedly hospitalized for heart failure, experiencing shortness of breath that prevented him from lying flat, progressively failing kidney function, and becoming entirely dependent on intravenous cardiac stimulants. These severe clinical symptoms placed him in the stage of end-stage heart failure, facing an extremely high risk of sudden cardiac death and pump failure. His cardiac surgeon told him, “You need a new heart, but here, the wait could be more than two years; you can’t afford to wait.”
2. Our Value: Cracking the Information Black Box of "Transnational Heart Transplantation"
International coordination for heart transplantation is one of the most complex scenarios in the field of organ transplantation. It involves a series of highly specialized aspects, including organ allocation policies, immune matching, donor procurement, international transport, and postoperative immunosuppression. When Ahmed's family approached us, they knew nothing about these aspects. Faced with this weighty expectation, we paved a clear path for Ahmed's family from "information fog" to "life restart."
This journey began with a data-driven global resource navigation exercise. We compiled a "Global Heart Transplant Center Comparison Report" for Ahmed, focusing on waiting times, surgical volumes, post-operative survival rates, and policies for accepting foreign patients at major transplant centers in China, the United States, and Europe. We clearly pointed out that some top heart transplant centers in China have significant advantages in terms of waiting times, and their one-year post-operative survival rates are on par with international best practices. This objective data-driven analysis led Ahmed and his family to decide to travel to China to await their transplant.
Before Ahmed's departure, we had already paved a "direct route" for him to the Heart Transplant Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. We translated and compiled all of Ahmed's medical records, imaging data, and cardiac catheterization reports in advance and submitted them to the expert team at Union Hospital for remote evaluation. After the experts confirmed his acceptance and formulated a preliminary treatment plan, we immediately coordinated his bed in the Heart Transplant ICU and assisted in developing a detailed "Health Management Plan for the Transplant Waiting Period." This meant that Ahmed did not depart with uncertainty and anxiety, but rather with a definite confirmation of acceptance and a clear waiting period management plan, heading to China.
During the "life support" phase while waiting for a donor, our role is that of a "transparent information conduit." After Ahmed was admitted to the hospital, our case manager communicated with the ICU medical team every day, keeping his family in Dubai informed of changes in his condition (such as weight, fluid intake and output, and medication adjustments), so that they could at least receive timely and transparent information during their anxious wait.
When a donor match is found, we immediately activate our most efficient "emergency response mechanism." When a matching heart becomes available, time is measured in minutes. Upon receiving notification from the hospital, our coordinators immediately assist the family in translating and explaining surgical consent documents, coordinating pre-operative consultations, and arranging for the family's waiting and rest during the surgery. Throughout the entire process, we act as the most efficient communication bridge between the hospital and the family.
3. Post-diagnosis services and follow-up: Safeguarding the long-term beating of a "new heart"
A successful heart transplant is only the first step in a long journey. Postoperative management of immunosuppression, rejection monitoring, infection prevention, and cardiovascular risk management determine how long this "new heart" can beat. Our post-operative service system revolves around the following three core aspects:
Precise management of immunosuppression. Rejection after heart transplantation is the most deadly threat. We established an "Immunosuppressive Drug Management File" for Ahmed, tracking his tacrolimus blood concentration, myocardial enzyme levels, electrocardiogram, and echocardiogram results weekly via a remote follow-up platform. If fluctuations in blood drug concentration or elevated myocardial enzymes are detected, we immediately activate the "rejection alert," assisting him in contacting his surgeon in China to determine whether an endomyocardial biopsy (the gold standard for diagnosing rejection) is necessary or if medication adjustments are required.
Infection prevention and cardiovascular risk management. Long-term immunosuppression placed Ahmed at high risk of infection and cardiovascular disease. Following his doctor's orders, we developed a "Postoperative Infection Prevention Checklist" and a "Cardiovascular Risk Control Plan" for him, including: vaccination reminders, oral hygiene management, regular monitoring of blood pressure, blood lipids, and blood glucose, and dietary and exercise recommendations. These seemingly trivial management measures are crucial for preventing long-term complications and prolonging the survival time of the transplanted heart.
Regular return trips to China for comprehensive evaluation. Based on the transplant center's follow-up plan, we schedule Ahmed's annual return to China for a comprehensive evaluation, including: coronary angiography (to rule out transplant-related cardiac vascular disease), endomyocardial biopsy, cardiac MRI, and immune status assessment. All results are compiled into an "Annual Heart Transplant Follow-up Report" by our case manager and simultaneously sent to the transplant team in China and the cardiologist in Dubai.
4. Therapeutic Effects and Insights
Three years after the transplant, Ahmed's heart function returned to normal, and his EF improved to 60%. He returned to his company and was able to engage in light activities such as jogging and swimming. In an email to us, he wrote: "You gave me a 'Chinese heart,' and more importantly, you gave me a complete plan to protect that heart. I know that no matter what problems I encounter in Dubai, I have a professional team supporting me. This sense of security is priceless."